Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Oncotargets and Therapy|September 15, 2018
miR-361-5p inhibits glioma migration and invasion by targeting SND1Jing Liu, Jie Yang, Lin Yu, et al.
Cancer Science|March 14, 2024
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinomaZhiduan Cai, Wenjun Luo, Haoran Wang, et al.
Basic & Clinical Pharmacology & Toxicology|March 5, 2026
Vericiguat as a Novel Ferroptosis Inhibitor Alleviates Doxorubicin-Induced CardiotoxicityHuiwen Han, Tao Luo, Canzhao Liu, et al.
The American Journal of Pathology|October 13, 2018
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' PrognosisWenjun Luo, Cuiyun Sun, Junhu Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2025
Innate immune-cell-derived BAFF promotes inflammatory response of ICOSL⁺ B cells via non-canonical NF-κB in diabetic autoimmunityZeying Li, Mingjiu Zhao, Wenjun Luo, et al.
British Journal of Cancer|August 9, 2017
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patientsCuijuan Shi, Linlin Ren, Cuiyun Sun, et al.
Horticulture Research|March 2, 2026
Chromosome-specific painting provides insights into the karyotype evolutionary direction and trajectory in the genus <i>Medicago</i>Wei Wang, Yuanbin Zhu, Xia Wu, et al.
Life Sciences|December 31, 2023
Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for gliomaWenzhe An, Qingqing Yang, Yunlan Xi, et al.
Oncotarget|February 5, 2017
miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patientsHuining Li, Lin Yu, Jing Liu, et al.
Journal of Translational Medicine|February 14, 2025
ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in gliomaYunlan Xi, Qingqing Yang, Yixuan Wang, et al.
Pageof 15